세계의 망막용 약제 시장 (2023~2027) : 병원 약국, 소매 약국, 온라인 약국

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Indication
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global retinal drugs market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global retinal drugs market 2017 – 2021 ($ million)
o 4.2 Ditribution channel Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Ditribution channel Segment 2017 – 2021 ($ million)
o 4.3 Indication Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Indication Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Hospital pharmacy – Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
o 6.4 Retail pharmacy – Market size and forecast 2022-2027
o Exhibit 38: Chart on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Retail pharmacy – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Retail pharmacy – Year-over-year growth 2022-2027 (%)
o 6.5 Online pharmacy – Market size and forecast 2022-2027
o Exhibit 42: Chart on Online pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Online pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Online pharmacy – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Online pharmacy – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Indication
o 7.1 Market segments
o Exhibit 47: Chart on Indication – Market share 2022-2027 (%)
o Exhibit 48: Data Table on Indication – Market share 2022-2027 (%)
o 7.2 Comparison by Indication
o Exhibit 49: Chart on Comparison by Indication
o Exhibit 50: Data Table on Comparison by Indication
o 7.3 Macular degeneration – Market size and forecast 2022-2027
o Exhibit 51: Chart on Macular degeneration – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Macular degeneration – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Macular degeneration – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Macular degeneration – Year-over-year growth 2022-2027 (%)
o 7.4 Diabetic eye disease – Market size and forecast 2022-2027
o Exhibit 55: Chart on Diabetic eye disease – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Diabetic eye disease – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Diabetic eye disease – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Diabetic eye disease – Year-over-year growth 2022-2027 (%)
o 7.5 Others – Market size and forecast 2022-2027
o Exhibit 59: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Indication
o Exhibit 63: Market opportunity by Indication ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 65: Chart on Market share by geography 2022-2027 (%)
o Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 67: Chart on Geographic comparison
o Exhibit 68: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 69: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 73: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 77: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 81: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 85: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 89: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 93: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 Spain – Market size and forecast 2022-2027
o Exhibit 97: Chart on Spain – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Spain – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Spain – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Spain – Year-over-year growth 2022-2027 (%)
o 9.11 Canada – Market size and forecast 2022-2027
o Exhibit 101: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 105: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 106: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 108: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 109: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 110: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 111: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 112: AbbVie Inc. – Overview
o Exhibit 113: AbbVie Inc. – Product / Service
o Exhibit 114: AbbVie Inc. – Key news
o Exhibit 115: AbbVie Inc. – Key offerings
o 12.4 Alcon Inc.
o Exhibit 116: Alcon Inc. – Overview
o Exhibit 117: Alcon Inc. – Business segments
o Exhibit 118: Alcon Inc. – Key offerings
o Exhibit 119: Alcon Inc. – Segment focus
o 12.5 Alimera Sciences Inc.
o Exhibit 120: Alimera Sciences Inc. – Overview
o Exhibit 121: Alimera Sciences Inc. – Product / Service
o Exhibit 122: Alimera Sciences Inc. – Key offerings
o 12.6 Bausch Health Co Inc.
o Exhibit 123: Bausch Health Co Inc. – Overview
o Exhibit 124: Bausch Health Co Inc. – Business segments
o Exhibit 125: Bausch Health Co Inc. – Key news
o Exhibit 126: Bausch Health Co Inc. – Key offerings
o Exhibit 127: Bausch Health Co Inc. – Segment focus
o 12.7 Bayer AG
o Exhibit 128: Bayer AG – Overview
o Exhibit 129: Bayer AG – Business segments
o Exhibit 130: Bayer AG – Key news
o Exhibit 131: Bayer AG – Key offerings
o Exhibit 132: Bayer AG – Segment focus
o 12.8 Bristol Myers Squibb Co.
o Exhibit 133: Bristol Myers Squibb Co. – Overview
o Exhibit 134: Bristol Myers Squibb Co. – Product / Service
o Exhibit 135: Bristol Myers Squibb Co. – Key news
o Exhibit 136: Bristol Myers Squibb Co. – Key offerings
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 137: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 138: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 139: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 140: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 141: F. Hoffmann La Roche Ltd. – Segment focus
o 12.10 Johnson and Johnson Services Inc.
o Exhibit 142: Johnson and Johnson Services Inc. – Overview
o Exhibit 143: Johnson and Johnson Services Inc. – Business segments
o Exhibit 144: Johnson and Johnson Services Inc. – Key news
o Exhibit 145: Johnson and Johnson Services Inc. – Key offerings
o Exhibit 146: Johnson and Johnson Services Inc. – Segment focus
o 12.11 MeiraGTx Holdings Plc
o Exhibit 147: MeiraGTx Holdings Plc – Overview
o Exhibit 148: MeiraGTx Holdings Plc – Product / Service
o Exhibit 149: MeiraGTx Holdings Plc – Key offerings
o 12.12 Novartis AG
o Exhibit 150: Novartis AG – Overview
o Exhibit 151: Novartis AG – Business segments
o Exhibit 152: Novartis AG – Key offerings
o Exhibit 153: Novartis AG – Segment focus
o 12.13 Ocular Therapeutix Inc.
o Exhibit 154: Ocular Therapeutix Inc. – Overview
o Exhibit 155: Ocular Therapeutix Inc. – Product / Service
o Exhibit 156: Ocular Therapeutix Inc. – Key offerings
o 12.14 Oxurion NV
o Exhibit 157: Oxurion NV – Overview
o Exhibit 158: Oxurion NV – Product / Service
o Exhibit 159: Oxurion NV – Key offerings
o 12.15 Pfizer Inc.
o Exhibit 160: Pfizer Inc. – Overview
o Exhibit 161: Pfizer Inc. – Product / Service
o Exhibit 162: Pfizer Inc. – Key news
o Exhibit 163: Pfizer Inc. – Key offerings
o 12.16 Regeneron Pharmaceuticals Inc.
o Exhibit 164: Regeneron Pharmaceuticals Inc. – Overview
o Exhibit 165: Regeneron Pharmaceuticals Inc. – Product / Service
o Exhibit 166: Regeneron Pharmaceuticals Inc. – Key offerings
o 12.17 Sanofi SA
o Exhibit 167: Sanofi SA – Overview
o Exhibit 168: Sanofi SA – Business segments
o Exhibit 169: Sanofi SA – Key news
o Exhibit 170: Sanofi SA – Key offerings
o Exhibit 171: Sanofi SA – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 172: Inclusions checklist
o Exhibit 173: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 174: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 175: Research methodology
o Exhibit 176: Validation techniques employed for market sizing
o Exhibit 177: Information sources
o 13.5 List of abbreviations
o Exhibit 178: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary – Chart on Market Segmentation by Indication
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global retinal drugs market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Ditribution channel Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Indication Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Retail pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Retail pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Online pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Online pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Online pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Online pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Chart on Indication – Market share 2022-2027 (%)
Exhibits48: Data Table on Indication – Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by Indication
Exhibits50: Data Table on Comparison by Indication
Exhibits51: Chart on Macular degeneration – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Macular degeneration – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Macular degeneration – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Macular degeneration – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Diabetic eye disease – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Diabetic eye disease – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Diabetic eye disease – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Diabetic eye disease – Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits63: Market opportunity by Indication ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share by geography 2022-2027 (%)
Exhibits66: Data Table on Market share by geography 2022-2027 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Spain – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Spain – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Spain – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Spain – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits105: Market opportunity by geography ($ million)
Exhibits106: Impact of drivers and challenges in 2022 and 2027
Exhibits107: Overview on Criticality of inputs and Factors of differentiation
Exhibits108: Overview on factors of disruption
Exhibits109: Impact of key risks on business
Exhibits110: Vendors covered
Exhibits111: Matrix on vendor position and classification
Exhibits112: AbbVie Inc. – Overview
Exhibits113: AbbVie Inc. – Product / Service
Exhibits114: AbbVie Inc. – Key news
Exhibits115: AbbVie Inc. – Key offerings
Exhibits116: Alcon Inc. – Overview
Exhibits117: Alcon Inc. – Business segments
Exhibits118: Alcon Inc. – Key offerings
Exhibits119: Alcon Inc. – Segment focus
Exhibits120: Alimera Sciences Inc. – Overview
Exhibits121: Alimera Sciences Inc. – Product / Service
Exhibits122: Alimera Sciences Inc. – Key offerings
Exhibits123: Bausch Health Co Inc. – Overview
Exhibits124: Bausch Health Co Inc. – Business segments
Exhibits125: Bausch Health Co Inc. – Key news
Exhibits126: Bausch Health Co Inc. – Key offerings
Exhibits127: Bausch Health Co Inc. – Segment focus
Exhibits128: Bayer AG – Overview
Exhibits129: Bayer AG – Business segments
Exhibits130: Bayer AG – Key news
Exhibits131: Bayer AG – Key offerings
Exhibits132: Bayer AG – Segment focus
Exhibits133: Bristol Myers Squibb Co. – Overview
Exhibits134: Bristol Myers Squibb Co. – Product / Service
Exhibits135: Bristol Myers Squibb Co. – Key news
Exhibits136: Bristol Myers Squibb Co. – Key offerings
Exhibits137: F. Hoffmann La Roche Ltd. – Overview
Exhibits138: F. Hoffmann La Roche Ltd. – Business segments
Exhibits139: F. Hoffmann La Roche Ltd. – Key news
Exhibits140: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits141: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits142: Johnson and Johnson Services Inc. – Overview
Exhibits143: Johnson and Johnson Services Inc. – Business segments
Exhibits144: Johnson and Johnson Services Inc. – Key news
Exhibits145: Johnson and Johnson Services Inc. – Key offerings
Exhibits146: Johnson and Johnson Services Inc. – Segment focus
Exhibits147: MeiraGTx Holdings Plc – Overview
Exhibits148: MeiraGTx Holdings Plc – Product / Service
Exhibits149: MeiraGTx Holdings Plc – Key offerings
Exhibits150: Novartis AG – Overview
Exhibits151: Novartis AG – Business segments
Exhibits152: Novartis AG – Key offerings
Exhibits153: Novartis AG – Segment focus
Exhibits154: Ocular Therapeutix Inc. – Overview
Exhibits155: Ocular Therapeutix Inc. – Product / Service
Exhibits156: Ocular Therapeutix Inc. – Key offerings
Exhibits157: Oxurion NV – Overview
Exhibits158: Oxurion NV – Product / Service
Exhibits159: Oxurion NV – Key offerings
Exhibits160: Pfizer Inc. – Overview
Exhibits161: Pfizer Inc. – Product / Service
Exhibits162: Pfizer Inc. – Key news
Exhibits163: Pfizer Inc. – Key offerings
Exhibits164: Regeneron Pharmaceuticals Inc. – Overview
Exhibits165: Regeneron Pharmaceuticals Inc. – Product / Service
Exhibits166: Regeneron Pharmaceuticals Inc. – Key offerings
Exhibits167: Sanofi SA – Overview
Exhibits168: Sanofi SA – Business segments
Exhibits169: Sanofi SA – Key news
Exhibits170: Sanofi SA – Key offerings
Exhibits171: Sanofi SA – Segment focus
Exhibits172: Inclusions checklist
Exhibits173: Exclusions checklist
Exhibits174: Currency conversion rates for US$
Exhibits175: Research methodology
Exhibits176: Validation techniques employed for market sizing
Exhibits177: Information sources
Exhibits178: List of abbreviations